Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $0.37 in the prior trading day, BioAffinity Technologies Inc (NASDAQ: BIAF) closed at $0.29, down -20.44%. In other words, the price has decreased by -$20.44 from its previous closing price. On the day, 0.54 million shares were traded. BIAF stock price reached its highest trading level at $0.355 during the session, while it also had its lowest trading level at $0.2812.
Ratios:
Our goal is to gain a better understanding of BIAF by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.01 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.30.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIAF now has a Market Capitalization of 5262745 and an Enterprise Value of 5513529. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.49 while its Price-to-Book (P/B) ratio in mrq is 1.26. Its current Enterprise Value per Revenue stands at 0.589 whereas that against EBITDA is -0.724.
Stock Price History:
The Beta on a monthly basis for BIAF is 3.16, which has changed by -0.8589372 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, BIAF has reached a high of $3.16, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is -56.90%, while the 200-Day Moving Average is calculated to be -80.18%.
Shares Statistics:
The stock has traded on average 222.25K shares per day over the past 3-months and 368920 shares per day over the last 10 days, according to various share statistics. A total of 13.42M shares are outstanding, with a floating share count of 9.42M. Insiders hold about 39.53% of the company’s shares, while institutions hold 3.44% stake in the company. Shares short for BIAF as of 1740700800 were 115473 with a Short Ratio of 0.52, compared to 1738281600 on 396793. Therefore, it implies a Short% of Shares Outstanding of 115473 and a Short% of Float of 0.95.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
BioAffinity Technologies Inc (BIAF) is presently subject to a detailed evaluation by 1 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.17 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.69 and -$0.69 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is -$0.66, with 1.0 analysts recommending between -$0.66 and -$0.66.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $2.62M. There is a high estimate of $2.62M for the next quarter, whereas the lowest estimate is $2.62M.
Based on 1 analysts’ estimates, the company’s revenue will be $11.49M in the next fiscal year. The high estimate is $11.49M and the low estimate is $11.49M.
